Betamethasone dipropionate

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 29.10.2020

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Highly effective halogenated glucocorticoid.

IndicationThis section has been translated automatically.

Eczema, allergic skin reactions, in persistent cases also short-term as interval or tandem therapy for psoriasis vulgaris.

Notice! Application duration max. 4 weeks!

Limited indicationThis section has been translated automatically.

Pregnancy, children < 2 years, application on the eye.

Dosage and method of useThis section has been translated automatically.

Topical: Cream/gel/ointment: Apply 1-2 times/day thinly to the affected skin areas, if necessary under occlusion.

Standard concentrationThis section has been translated automatically.

0.064% in cream, ointment, gel.

PreparationsThis section has been translated automatically.

Diprosis; Diprosone; Xamiol (combination with calcipotriol)

Note(s)This section has been translated automatically.

For moderately severe psoriasis capitis, a ready-to-use preparation with a betamethasone dipropionate/calcipotriol formulation in a gel base is available (Xamiol).

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer